Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Daliresp

Roflumilast

Open in the dashboard

Part D claims

2,622

Prescriptions dispensed, refills included

Drug cost

$1,149,566

Paid at the pharmacy, in all

Prescribers

185

With 11 or more claims of it

In 2024, Medicare Part D recorded 2,622 claims for Daliresp (roflumilast) from 185 prescribers, at a total drug cost of $1.1 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 37 states and territories
Part D claims for Daliresp by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
NY 19 310 $138,198
OH 17 277 $114,288
PA 17 247 $99,259
CA 13 174 $69,061
KY 10 151 $62,695
NJ 11 147 $66,172
IN 8 122 $57,832
TN 8 107 $49,449
NC 6 86 $38,273
PR 6 82 $34,729
MA 6 79 $36,549
TX 6 70 $31,763
GA 5 61 $25,634
MO 5 61 $32,654
FL 5 58 $21,547
The other 22 states and territories
State Prescribers Claims Drug cost
WI 4 58 $33,542
MN 4 50 $20,777
ME 3 44 $21,446
ID 3 44 $19,068
OK 2 40 $16,973
OR 3 38 $15,056
CT 2 37 $22,346
AZ 3 35 $15,345
AR 2 32 $9,969
MS 2 26 $11,396
MI 2 23 $9,918
KS 2 22 $9,979
VA 2 22 $9,613
NH 1 17 $10,463
NV 1 16 $6,836
IA 1 14 $5,820
NE 1 13 $5,053
WV 1 12 $5,237
AL 1 12 $5,496
LA 1 12 $5,227
WA 1 12 $7,101
MD 1 11 $4,804

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 7 of 7
Part D claims for Daliresp by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Pulmonary Disease 76 1,077 $511,648
Nurse Practitioner 39 545 $248,103
Internal Medicine 30 413 $163,189
Family Practice 23 339 $126,089
Physician Assistant 8 122 $47,163
Critical Care (Intensivists) 8 114 $47,984
General Practice 1 12 $5,391

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Tamrat Bekele Internal Medicine PA 40 $4,526 None on record
Jennifer Maag Family Practice OH 32 $6,964 None on record
Christy Martin Nurse Practitioner OH 31 $15,873 None on record
Xiwu John Sun Pulmonary Disease NY 29 $13,657 None on record
Arun Devakonda Pulmonary Disease OK 27 $11,428 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for roflumilast

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record